WO2003004047A1 - Inducteurs de mort cellulaire pour des mastocytes - Google Patents
Inducteurs de mort cellulaire pour des mastocytes Download PDFInfo
- Publication number
- WO2003004047A1 WO2003004047A1 PCT/JP2002/006790 JP0206790W WO03004047A1 WO 2003004047 A1 WO2003004047 A1 WO 2003004047A1 JP 0206790 W JP0206790 W JP 0206790W WO 03004047 A1 WO03004047 A1 WO 03004047A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- mast cells
- variant
- mitf
- cell death
- ptd
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
- Coils Or Transformers For Communication (AREA)
- Soft Magnetic Materials (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE60222265T DE60222265T2 (de) | 2001-07-05 | 2002-07-04 | Zelltod-induktoren für mastzellen |
EP02743832A EP1410802B1 (en) | 2001-07-05 | 2002-07-04 | Cell death inducers for mast cells |
US10/482,793 US7217539B2 (en) | 2001-07-05 | 2002-07-04 | Cell death inducers for mast cells |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001-204567 | 2001-07-05 | ||
JP2001204567A JP2003009883A (ja) | 2001-07-05 | 2001-07-05 | マスト細胞の細胞死誘発剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003004047A1 true WO2003004047A1 (fr) | 2003-01-16 |
Family
ID=19041009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2002/006790 WO2003004047A1 (fr) | 2001-07-05 | 2002-07-04 | Inducteurs de mort cellulaire pour des mastocytes |
Country Status (6)
Country | Link |
---|---|
US (1) | US7217539B2 (ja) |
EP (1) | EP1410802B1 (ja) |
JP (1) | JP2003009883A (ja) |
AT (1) | ATE372347T1 (ja) |
DE (1) | DE60222265T2 (ja) |
WO (1) | WO2003004047A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100685345B1 (ko) | 2004-03-27 | 2007-02-22 | 학교법인조선대학교 | 세포사 유도 펩타이드 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005117928A1 (en) * | 2004-05-30 | 2005-12-15 | Cemines, Inc. | Compositions and methods for the treatment of skin cancer |
CN101016340A (zh) * | 2007-01-18 | 2007-08-15 | 夏献民 | 融合多肽及其在肿瘤与细胞生长异常相关的疾病治疗中的用途 |
CA2936675C (en) | 2014-01-12 | 2023-06-27 | Igf Oncology, Llc | Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof |
KR102619496B1 (ko) | 2016-07-19 | 2023-12-29 | 유니버시티 오브 피츠버그-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | Stat3를 타겟으로 하는 종양용해성 바이러스 |
AU2018273370A1 (en) | 2017-05-21 | 2019-10-31 | Igf Oncology, Llc | An insulin-like growth factor-chemotherapeputic conjugate for treating myelodysplastic syndrome |
CA3215344A1 (en) | 2021-04-30 | 2022-11-03 | Kalivir Immunotherapeutics, Inc. | Oncolytic viruses for modified mhc expression |
PL244930B1 (pl) | 2021-12-08 | 2024-04-02 | Gdanski Univ Medyczny | Zastosowanie 2-metoksyestradiolu w leczeniu mastocytozy |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991009958A2 (en) * | 1989-12-21 | 1991-07-11 | Whitehead Institute For Biomedical Research | Method of delivering molecules into eukaryotic cells |
WO1999010376A1 (en) * | 1997-08-22 | 1999-03-04 | Washington University | Inducible regulatory system and use thereof |
WO2000047765A1 (en) * | 1999-02-08 | 2000-08-17 | Marie Curie Cancer Care | Materials and methods relating to the detection of a cancer cell marker |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001066735A1 (fr) | 2000-03-08 | 2001-09-13 | Mitsubishi Pharma Corporation | Protéines associées au mitf |
-
2001
- 2001-07-05 JP JP2001204567A patent/JP2003009883A/ja active Pending
-
2002
- 2002-07-04 DE DE60222265T patent/DE60222265T2/de not_active Expired - Lifetime
- 2002-07-04 EP EP02743832A patent/EP1410802B1/en not_active Expired - Lifetime
- 2002-07-04 WO PCT/JP2002/006790 patent/WO2003004047A1/ja active IP Right Grant
- 2002-07-04 US US10/482,793 patent/US7217539B2/en not_active Expired - Fee Related
- 2002-07-04 AT AT02743832T patent/ATE372347T1/de not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991009958A2 (en) * | 1989-12-21 | 1991-07-11 | Whitehead Institute For Biomedical Research | Method of delivering molecules into eukaryotic cells |
WO1999010376A1 (en) * | 1997-08-22 | 1999-03-04 | Washington University | Inducible regulatory system and use thereof |
WO2000047765A1 (en) * | 1999-02-08 | 2000-08-17 | Marie Curie Cancer Care | Materials and methods relating to the detection of a cancer cell marker |
Non-Patent Citations (4)
Title |
---|
MOORE KAREN J.: "Insight into the microphthalmia gene", TRENDS IN GENETICS, vol. 11, no. 11, November 1995 (1995-11-01), pages 442 - 448, XP004207440 * |
OGIHARA HIDEKI ET AL.: "Inhibitory effect of the transcription factor encoded by the mutant mi microphthalmia allele on transactivation of mouse mast cell protease 7 gene", BLOOD, vol. 97, no. 3, 1 February 2001 (2001-02-01), pages 645 - 651, XP002958936 * |
TSUJIMURA TOHRU ET AL.: "Involvement of transcription factor encoded by the mi locus in the expression of c-kit receptor tyrosine kinase in cultured mast cells of mice", BLOOD, vol. 88, no. 4, 15 August 1996 (1996-08-15), pages 1225 - 1233, XP002940677 * |
TSUJIMURA TOHRU ET AL.: "Involvement of transcription factor encoded by the mouse mi locus (MITF) in apoptosis of cultured mast cells induced by removal of interleukin-3", AMERICAN JOURNAL OF PATHOLOGY, vol. 151, no. 4, October 1997 (1997-10-01), pages 1043 - 1051, XP002958935 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100685345B1 (ko) | 2004-03-27 | 2007-02-22 | 학교법인조선대학교 | 세포사 유도 펩타이드 |
Also Published As
Publication number | Publication date |
---|---|
JP2003009883A (ja) | 2003-01-14 |
EP1410802B1 (en) | 2007-09-05 |
US7217539B2 (en) | 2007-05-15 |
EP1410802A1 (en) | 2004-04-21 |
EP1410802A4 (en) | 2005-04-13 |
US20040248787A1 (en) | 2004-12-09 |
ATE372347T1 (de) | 2007-09-15 |
DE60222265T2 (de) | 2008-06-19 |
DE60222265D1 (de) | 2007-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Henry et al. | Caspase-8 acts in a non-enzymatic role as a scaffold for assembly of a pro-inflammatory “FADDosome” complex upon TRAIL stimulation | |
IL210455A (en) | A polypeptide for reducing mammalian signaling 13il, and using a polypeptide to produce a drug for up-regulating gene expression 2ra13-il in mammals | |
MXPA03002218A (es) | Peptidos antimicrobianos y metodos de uso. | |
DE59711812D1 (de) | Rekombinante collagenase typ i aus clostridium histolyticum und ihre verwendung zur isolierung von zellen und zellverbänden | |
DE69635899D1 (de) | Polypeptid, das die differenzierung unterdrueckt | |
ATE384798T1 (de) | Polypeptide mit phytase-aktivität und sie kodierende nukleinsäuren | |
ATE309358T1 (de) | Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein | |
ATE257859T1 (de) | Humanes, rekombinantes interferon-beta mit verbesserter löslichkeit | |
EP2011510A3 (en) | Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments | |
WO2003004047A1 (fr) | Inducteurs de mort cellulaire pour des mastocytes | |
WO2003048205A3 (fr) | Proteines a activite inhibitrice de l'il-6 | |
WO2000056866A3 (en) | Akt-3 nucleic acids, polypeptides, and uses thereof | |
RU97103147A (ru) | Днк-последовательности, кодирующие человеческие протеины тх и ту, родственные конвергирующему интерлейкин-1-бета ферменту | |
MXPA02007751A (es) | Acido desoxirribonucleico que codifica receptor vaniloide vr3. | |
WO2001005826A3 (en) | Chimeric polypeptides of serum albumin and uses related thereto | |
PE20001068A1 (es) | Produccion de analogos de tripsinogeno recombinante solubles | |
WO2001094414A3 (en) | THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE | |
WO2003025182A1 (fr) | Adn de surexpression d'une hormone de croissance et utilisation | |
EP1427825B8 (en) | Cdna encoding the human alpha2 delta4 calcium channel subunit | |
WO2002012475A3 (en) | C1q-related factor, homologous polypeptides and therapeutic uses thereof | |
WO2004048409A3 (en) | Mutants of the tumor necrosis factor alpha with deletion of n-terminal amino acids | |
EP1577387A4 (en) | PREVENTIVE DRUGS / REMEDIES FOR CANCER | |
AU2003222959A1 (en) | Use of alpha-s2 casein precursor-derived peptided | |
DE60138885D1 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen | |
WO2001079431A3 (fr) | Nouveau polypeptide, proteine humaine d'interaction 15 avec la proteine huntingtine, et polynucleotide codant pour ce polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002743832 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002743832 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10482793 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002743832 Country of ref document: EP |